Young-Jin Kim

CIK: 0001768406

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RZLT

Rezolute, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

RZLT
Rezolute, Inc.
Nov 19, 2025
Award(A)
Direct
21K shares-
RZLT
Rezolute, Inc.
Jun 13, 2025
Purchase(P)
Indirect
1.2M shares at avg. $3.25$4.0M
RZLT
Rezolute, Inc.
Jun 10, 2025
Award(A)
Direct
9K shares-
RZLT
Rezolute, Inc.
Feb 16, 2025
Award(A)
Direct
25.5K shares-
RZLT
Rezolute, Inc.
Jun 25, 2024
Purchase(P)
Indirect
1.3M shares at avg. $4.00$5.0M

		Type	Shares	Price		Ownership
Nov 19, 2025	RZLT Rezolute, Inc.	Award(A)	21,000	-	-	Direct
Jun 13, 2025	RZLT Rezolute, Inc.	Purchase(P)	1,230,769	$3.25	$3,999,999	Indirect
Jun 10, 2025	RZLT Rezolute, Inc.	Award(A)	9,000	-	-	Direct
Feb 16, 2025	RZLT Rezolute, Inc.	Award(A)	25,500	-	-	Direct
Jun 25, 2024	RZLT Rezolute, Inc.	Purchase(P)	1,250,000	$4.00	$5,000,000	Indirect

1-5 of 5 transactions

About Kim Young-Jin

Kim Young-Jin (SEC CIK 0001768406) files insider reports with the SEC as Director of Rezolute, Inc. (RZLT).

Signal8 holds 4 ownership filings by Kim Young-Jin, all Form 4s, filed between Feb 19, 2025 and Nov 21, 2025. Those filings report 5 transactions, from Jun 25, 2024 to Nov 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Kim Young-Jin's filings is in REDWOOD CITY, CA.

Recent filings by Kim Young-Jin

Nov 19, 2025: Grant or award of RZLT shares (Form 4, code A).
Jun 13, 2025: Open-market purchase of RZLT shares (Form 4, code P).
Jun 10, 2025: Grant or award of RZLT shares (Form 4, code A).
Feb 16, 2025: Grant or award of RZLT shares (Form 4, code A).
Jun 25, 2024: Open-market purchase of RZLT shares (Form 4, code P).

Other insiders filing for Rezolute, Inc. (RZLT)

Evans Daron, CFO
Karnawat Sunil Ratilal, Chief Commercial Officer
ROBERTS BRIAN KENNETH, Chief Medical Officer
Elam Nevan C, CEO
Hogenhuis Wladimir, Director
KREHER NERISSA, Director

How to read Form 4 transaction codes